Study of Colorectal Procedures With the Levita Magnetic Surgical System
- Conditions
- Colorectal Procedures
- Interventions
- Device: Levita Magnetic Surgical System
- Registration Number
- NCT03960684
- Lead Sponsor
- Levita Magnetics
- Brief Summary
The purpose of this study is to evaluate the safety and effectiveness of the Levita Magnetic Surgical System in patients undergoing colorectal procedures.
- Detailed Description
Prospective, multicenter, single-arm, open label study designed to assess the safety and effectiveness of the Levita Magnetic Surgical System in colorectal procedures.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 31
- Subject is at least 18 years of age
- Subject is scheduled to undergo elective colorectal surgery
- Significant comorbidities
- Subjects with pacemakers, defibrillators, or other electromedical implants
- Subjects with ferromagnetic implants
- Clinical history of impaired coagulation
- Subject has an anatomical abnormality noted after initiation of index procedure that would prevent device use
- Subject is not likely to comply with the follow-up evaluation schedule
- Subject is participating in another clinical trial
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description Levita Magnetic Surgical System Levita Magnetic Surgical System Levita Magnetic Surgical System
- Primary Outcome Measures
Name Time Method Number and Types of Tools Required to Retract the Colon or Peri-colorectal Tissues During planned colorectal procedure Ability to adequately retract the colon, peri-colorectal tissues or adjacent organs to achieve an effective exposure of the target tissue. Adequate retraction is achieved if it is not necessary to replace the Levita Magnetic Surgical System with another instrument to retract these tissues during the procedure.
Cumulative number of additional tools required across all participants.Device Related Adverse Events Through 30 days post colorectal procedure/study completion. All adverse events will be recorded and allocated as to relatedness to device, procedure or other.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Hospital del Salvador
🇨🇱Santiago, Chile